Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist versus human chorionic gonadotropin for IVF outcome improvement
PACTR201506001132105Not yet recruiting
- Sponsor
- Magdy Ibrahim Mostafa
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of triptorelin and human chorionic gonadotropin in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Magdy Ibrahim Mostafa. Primary endpoint: Ongoing pregnancy rate. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
triptorelinhuman chorionic gonadotropin
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on PACTR201506001132105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201506001132105.